LSX: The Network For Life Science Executives.png

Home
About
Partners
Events
Digital
Resources
CONTACT US

Dr Jill Ogden

Principal at Medius Associates

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

Bullets are great
For spelling out benefits and
Turning visitors into leads.

LSX BLOG

Written By
Dr Jill Ogden

Reviewing life sciences deal trends

M&A and Deal Making LSX Report Expert Insight

17 September 2018

Posts by Dr Jill Ogden

September 17, 2018

Reviewing life sciences deal trends

For the first seven months of this year (to July) our Deal Watch analysis o...

Read More

Prev
Louise Fordham (68)

LSX (33)

Russell Gardiner (18)

Medius Associates (9)

Lea Bidiville (8)

Paul Gilbertson (6)

Neil Darkes (4)

Patrick Brennan (4)

CMS (3)

Ross Cummings (3)

Will Arends (3)

David Jasiewicz (2)

Lala Gregorek (2)

Marks & Clerk (2)

Terence O'Dwyer (2)

A. Sinclair Dunlop (1)

Alexandra Eavis (1)

Allen & Overy (1)

Amélie Wallenhammar (1)

Ann Gidner (1)

Anoop Maini (1)

Arnie Clarke (1)

Arve Voldsund (1)

Ashley Williams (1)

Barry Sharples (1)

Biotech & Money (1)

Carlos de Sousa (1)

Catherine Williamson (1)

Catherine Wolfe (1)

Christoph Kausch (1)

Claudia Gomez (1)

Covington (1)

Dan Levitt (1)

Daniel O’Mahony (1)

David Hammond (1)

David Mardle (1)

Dirk Pollet (1)

Dominic Endicott (1)

Dr Jill Ogden (1)

Dr Michael Hopkins (1)

Dr Stefan Fraenkel (1)

Duncan White (1)

Edward Ronan (1)

Ewa Campbell (1)

Executive Women In Bio (1)

Finn Nikolajsen (1)

Gary Green (1)

Hannah Netherton (1)

Helen Disney (1)

Howard Read (1)

Ian Jones (1)

Isobel Finnie (1)

James Shaw (1)

Jason C. Foster (1)

Jennifer Plitsch (1)

Johan Strömquist (1)

John Cassidy (1)

John Ratliff (1)

Josh Dance (1)

Josh Price (1)

Julia Gwilt (1)

Karin Conde-Knape (1)

Karolina Zapadka (1)

Katherine Keys (1)

Kiron Campbell (1)

Marc Lohrmann (1)

Mark Corbett (1)

Martin Olovsson (1)

Matthew S. Jones (1)

Michael Bloch (1)

Panos Constantinides (1)

Peter Sausen (1)

Rachel Bell (1)

Rachel Free (1)

Rachel Mercer (1)

Robert James (1)

Ruth Wright (1)

Sander Slootweg (1)

Sarah Dobson (1)

Simon Turner (1)

Stephan Christgau (1)

Steven Gurney (1)

Tara Raveendran (1)

Toby Sears (1)

Visa Sippola (1)

Viviane Joynes (1)

Xplico (1)
Next

Add Your Response

ABOUT THE BLOG

The LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.

CATEGORIES

Expert Insight (121)
Investment and IPOs (91)
Europe (63)
Biotech (62)
IP, Regulation and Compliance (56)
R&D to Commercialisation (54)
Event (43)
Digital Health (39)
LSX Report (38)
Medtech and Medical Devices (37)
UK (34)
M&A and Deal Making (30)
Case Study (24)
US (18)
White Paper (17)
Featured Content (16)
Talent and Executive Strategy (12)
Pharma (11)
Interview (7)
Investorview (7)
Video (7)
Webinar (5)
Asia Pacific (3)
Longevity (3)
MENA (2)

see all

Subscribe Email

UPCOMING CONFERENCE

UPCOMING CONFERENCE

Longevity 2020 Email Header 670x280 04

The 5th annual LSX World Congress is a high-calibre, senior executive, two-day conference and partnering event.

ABOUT US

LSX is an influential community of senior life science decision makers.

We connect senior biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

EVENTS

Longevity Leaders

LSX Nordic Congress: Virtual

Healthtech Leaders: Virtual

LSX USA CEO Forums: Virtual

Inv€$tival Showcase

European Lifestars Awards

LSX World Congress

Healthtech Leaders

Healthspan Show

LINKS

© 2020 All Rights Reserved By LSX Ltd | Privacy Policy